POLE and squamous cell carcinoma: In parallel, Liu et al. [128] investigated a cohort of 513 patients with lung adenocarcinoma and 497 with squamous cell carcinoma from The Cancer Genome Atlas (TCGA) to test the prognostic value of POLE mutations and PD-L1 expression.